News from diogenix, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 27, 2014, 08:00 ET

DioGenix Reports Positive Clinical Performance of Molecular Diagnostic MSPrecise for Multiple Sclerosis

DioGenix, Inc. announced today new data supporting the clinical validation of MSPrecise®, its proprietary next-generation sequencing (NGS)...

Dec 05, 2013, 07:30 ET

DioGenix Raises $3.2 Million for Novel Molecular Diagnostic for Multiple Sclerosis, MSPrecise

 DioGenix, Inc. announced today that it raised $3.2 million in a private financing consisting of new individual investors and returning...

Mar 18, 2013, 08:00 ET

DioGenix Issued Seminal Patent for Diagnosing Early-stage Neurological Diseases

DioGenix, Inc. announced today that the United States Patent and Trademark Office has issued a patent that broadly protects DioGenix' proprietary...

Dec 18, 2012, 08:00 ET

DioGenix Raises $1.5 Million in Series B Financing for Novel Molecular Diagnostic for Multiple Sclerosis, MSPrecise

Molecular diagnostics company DioGenix, Inc. today announced it raised $1.5 million in Series B financing. Existing investors including life...

Nov 08, 2012, 08:00 ET

DioGenix' MSPrecise Identifies Early-Stage Patients with Multiple Sclerosis

 DioGenix, Inc., a company developing molecular diagnostics for the early diagnosis and monitoring of immune-mediated neurological...

Nov 08, 2012, 08:00 ET

DioGenix and Fast Forward Collaborate to Develop Blood-Based Molecular Diagnostic for Multiple Sclerosis

DioGenix, Inc. today announced an alliance with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to develop a novel blood...